林 威宏

Medicine & Life Sciences

1. Escherichia coli 53%
2. Peritonitis 34%
3. Peritoneal Dialysis 33%
4. Community-Acquired Infections 30%
5. Chronic Kidney Failure 29%
6. Cohort Studies 27%
7. Type 1 Diabetes Mellitus 26%
8. Chronic Renal Insufficiency 25%
9. Infections 24%
10. Kidney 24%
11. Virulence Factors 22%
12. Incidence 22%
13. Uropathogenic Escherichia coli 21%
14. Plasmids 19%
15. Mortality 17%
16. Renal Dialysis 15%
17. Virulence 14%
18. Extraintestinal Pathogenic Escherichia coli 14%
19. Mass Spectrometry 13%
20. Population 13%
21. Anti-Infective Agents 13%
22. Escherichia coli Adhesins 12%
23. Staphylococcus lugdunensis 12%
24. ferric citrate 12%
25. Genes 12%
26. Genome 12%
27. Lasers 11%
28. CRISPR-Cas Systems 11%
29. Bacteremia 11%
30. Anti-Bacterial Agents 11%
31. Comorbidity 10%
32. Acarbose 10%
33. Rosuvastatin Calcium 10%
34. carbapenemase 9%
35. Urinary Bladder 9%
36. Dipeptidyl-Peptidase IV Inhibitors 9%
37. Oxacillin 9%
38. Frail Elderly 9%
39. Fluoroquinolones 9%
40. Bacteroides 9%